Prevalence and Predictors of Psychotropic Use in Children with High-Functioning ASDs

Table 2

Logistic regression results for the odds of taking a specific psychotropic medication class.

Model-medication class predictor	B	Wald	𝑃	Odds ratio
Stimulants^a
IQ	−.024	2.554	.110	1.02
DSD (ASD symptoms)	.056	4.743	.029*	1.06
Antidepressants^b
IQ	−.043	3.892	.049*	1.04
DSD (ASD symptoms)	.039	1.218	.270	1.04
Neuroleptics^c
IQ	−.059	4.210	.040*	1.06
DSD (ASD symptoms)	−.002	.002	.963	1.00

^∗𝑃<.05.
To aide interpretation, odds ratios for inverse relationships were transformed by 1/odds ratio.
Total sample size was 𝑁=115.
DSD: developmental social disorders subscale from the BASC-2.
^aReference group is children with HFASDs not taking a stimulant medication.
^bReference group is children with HFASDs not taking an antidepressant medication.
^cReference group is children with HFASDs not taking a neuroleptic medication.